[
  {
    "id": "fc_spirometry_2d9484da",
    "front": "Silica dust: IARC classification for cancer?",
    "back": "Group 1 human carcinogen (lung cancer)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_9550df2a",
    "front": "HIV infection: specific lung cancer risk?",
    "back": "Increased risk for lung malignancies",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_ad33e709",
    "front": "Silicosis increases risk for what infection?",
    "back": "Tuberculosis (TB)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_19433b74",
    "front": "Silica exposure links to what autoimmune diseases?",
    "back": "Scleroderma, ANCA-associated vasculitis",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_f3971cd9",
    "front": "Silica lung cancer risk: exposure relationship?",
    "back": "Yes, dose-response relationship",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_53d3ff5e",
    "front": "Silica exposure: lung cancer classification?",
    "back": "Group 1 carcinogen (IARC)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_59383241",
    "front": "HIV infection: increased lung cancer risk?",
    "back": "Yes; also Kaposi sarcoma, NHL",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_bf00af31",
    "front": "SCLC cell size and cytoplasm?",
    "back": "Small, scant cytoplasm, inconspicuous nucleoli.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_c52a5844",
    "front": "Adenocarcinoma positive IHC markers?",
    "back": "TTF-1 and Napsin A.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_91661bb7",
    "front": "Squamous Cell Carcinoma positive IHC?",
    "back": "p63, p40, CK5/6.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_594275b5",
    "front": "SCLC key nuclear features?",
    "back": "Finely granular chromatin ('salt and pepper'), nuclear molding.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_93563c6a",
    "front": "Major NSCLC histopathologic types?",
    "back": "Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_c5529478",
    "front": "NSCLC major histopathologic types?",
    "back": "Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_3df7e2ec",
    "front": "Adenocarcinoma key IHC markers?",
    "back": "TTF-1 positive, Napsin A positive",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_66024857",
    "front": "Squamous Cell Carcinoma key IHC markers?",
    "back": "p63 positive, CK5/6 positive; keratinization, intercellular bridges",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_3665a45a",
    "front": "SCLC key histopathologic features?",
    "back": "Small cells, scant cytoplasm, nuclear molding, high mitotic rate",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_67762e3b",
    "front": "SCLC key IHC markers?",
    "back": "Chromogranin, Synaptophysin, CD56 positive (neuroendocrine markers)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_8646f0fc",
    "front": "SCLC histology key feature?",
    "back": "Small, scant cytoplasm, nuclear molding, inconspicuous nucleoli.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_a06017e3",
    "front": "Adenocarcinoma IHC profile?",
    "back": "TTF-1, Napsin A, CK7 positive.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_c580a3c7",
    "front": "Squamous cell carcinoma IHC?",
    "back": "p63, CK5/6 positive.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_c5cd27f6",
    "front": "Adenocarcinoma histologic patterns?",
    "back": "Lepidic, acinar, papillary, micropapillary, solid.",
    "difficulty": "hard",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  },
  {
    "id": "fc_spirometry_3f301d79",
    "front": "SCLC chromatin characteristic?",
    "back": "Finely granular ('salt and pepper'), inconspicuous nucleoli.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Spirometry - Technique and Interpretation",
    "bookId": "spirometry",
    "sourceSection": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_5_OCR",
      "chapter": "Other Protocols for Measurement of Diffusing Capacity",
      "section": "PART 2 • Diagnosis and Evaluation of Respiratory Disease",
      "pageNumber": 42
    }
  }
]